ATARA BIOTHERAPEUTICS, INC. (ATRA) Dividend Safety
- Dividend payout ratio · 12 months: Value (m); Formula and calculation Cash dividends paid / net income. Period ending 2026-06-30..
Dividend safety
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Dividend payout ratio · 12 months | (m) | Cash dividends paid / net income. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Dividend payments · 12 months | (m) | |
| Net income · 12 months | -16.69M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Dividend payments · 12 months (USD) | Net income · 12 months (USD) | Dividend payout |
|---|---|---|---|
| 2026-06-30 | (m) | $-16.69M | (m) |
| 2026-03-31 | (m) | $-9.47M | (m) |
| 2025-12-31 | (m) | $32.69M | (m) |
| 2025-09-30 | (m) | $23.40M | (m) |
| 2025-06-30 | (m) | $5.79M | (m) |
| 2025-03-31 | (m) | $-15.64M | (m) |
| 2024-12-31 | (m) | $-85.40M | (m) |
| 2024-09-30 | (m) | $-133.16M | (m) |
| 2024-06-30 | (m) | $-181.05M | (m) |
| 2024-03-31 | (m) | $-233.11M | (m) |
| 2023-12-31 | (m) | $-276.13M | (m) |
| 2023-09-30 | (m) | $-290.25M | (m) |
| 2023-06-30 | (m) | $-304.54M | (m) |
| 2023-03-31 | (m) | $-214.97M | (m) |
| 2022-12-31 | (m) | $-228.30M | (m) |
| 2022-09-30 | (m) | $-247.08M | (m) |
| 2022-06-30 | (m) | $-247.65M | (m) |
| 2022-03-31 | (m) | $-349.91M | (m) |
| 2021-12-31 | (m) | $-340.14M | (m) |
| 2021-09-30 | (m) | $-328.10M | (m) |
| 2021-06-30 | (m) | $-317.78M | (m) |
| 2021-03-31 | (m) | $-311.45M | (m) |
| 2020-12-31 | (m) | $-306.62M | (m) |
| 2020-09-30 | (m) | $-303.81M | (m) |
| 2020-06-30 | (m) | $-301.36M | (m) |
| 2020-03-31 | (m) | $-298.23M | (m) |
| 2019-12-31 | (m) | $-290.98M | (m) |
| 2019-09-30 | (m) | $-292.49M | (m) |
| 2019-06-30 | (m) | $-278.96M | (m) |
| 2019-03-31 | (m) | $-255.51M | (m) |
| 2018-12-31 | (m) | $-230.70M | (m) |
| 2018-09-30 | (m) | $-186.00M | (m) |
| 2018-06-30 | (m) | $-158.74M | (m) |
| 2018-03-31 | (m) | $-135.28M | (m) |
| 2017-12-31 | (m) | $-119.49M | (m) |
| 2017-09-30 | (m) | $-102.41M | (m) |
| 2017-06-30 | (m) | $-96.69M | (m) |
| 2017-03-31 | (m) | $-88.14M | (m) |
| 2016-12-31 | (m) | $-79.05M | (m) |
| 2016-09-30 | (m) | $-82.06M | (m) |
| 2016-06-30 | (m) | $-68.56M | (m) |
| 2016-03-31 | (m) | $-64.62M | (m) |
| 2015-12-31 | (m) | $-57.22M | (m) |
| 2015-09-30 | (m) | $-46.50M | (m) |
| 2015-06-30 | (m) | $-40.55M | (m) |
| 2015-03-31 | (m) | $-30.12M | (m) |
| 2014-12-31 | (m) | $-28.01M | (m) |
| 2014-09-30 | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | (m) |
| 2014-03-31 | (m) | (m) | (m) |
| 2013-12-31 | (m) | $-8.77M | (m) |
| 2013-09-30 | (m) | (m) | (m) |
| 2012-12-31 | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |